NYSE:KMX charts & data provided by TradingView

Latest Insights on KMX

Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]
During the fund’s life, it has nearly doubled the performance of the S&P 500 Index. A $10,000 investment in the fund would have grown $100,000 more than in the S&P 500. Double the S&P 500 With Legendary Investor Bill Nygren April 11, 2019 by Brian Christopher Investing, Investment Opportunities, Winning Investor Daily During the fund’s life, it has nearly doubled the performance of the S&P 500 Index. A $10,000 investment in the fund would have grown $100,000 more than in the S&P 500.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Looks like I have finally found the right person to learn and grow from.”

- James

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

“Loving this. Should have started a long time ago.”

- Jay

Share This